---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-034210"
form_type: "8-K"
ticker: "KALA"
cik: "0001479419"
company_name: "KALA BIO, Inc."
filed_at: "2025-04-11T23:59:59+00:00"
generated_at: "2026-05-23T16:07:43.532381+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# KALA BIO enters retention agreements with three top executives; bonuses tied to CHASE trial data

## Summary
- Retention bonuses: Bazemore $281,190, Reumuth $234,000, Brazzell $260,000.
- Bonuses payable by April 18, 2025; clawback if executive resigns or is terminated for cause before earlier of Sept 30, 2025 or CHASE trial topline data announcement.
- CHASE trial of KPI-012 topline data expected Q3 2025 per exhibit.
- Coverage includes Interim CEO, CFO, and Head of R&D/CMO, focusing on retaining key personnel ahead of trial results.

## SEC filing metadata
- accession: 0001104659-25-034210
- form_type: 8-K
- ticker: KALA
- cik: 0001479419
- company_name: KALA BIO, Inc.
- filed_at: 2025-04-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479419/000110465925034210/0001104659-25-034210-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479419/000110465925034210/tm2512021d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-034210
- JSON: https://secwatch.observer/filing/0001104659-25-034210.json
- Plain text: https://secwatch.observer/filing/0001104659-25-034210.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.